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Background: Menstrual blood loss (MBL) has been shown to be an important determinant in iron status, work
performance and well-being. Several methods have been developed to estimate MBL, the standard quantitative
method however has limited application in clinical practice as it is expensive and requires women to collect, store
and submit their sanitary products for analysis. We therefore aimed to develop a MBL-score based on a questionnaire,
and to validate it by several hematological and biochemical parameters in women of childbearing age.
Methods: A total of 165 healthy young women were recruited. Hematological (hematocrit, hemoglobin, erythrocyte,
leucocyte and platelet counts) and iron status (serum iron, serum ferritin, serum transferrin, and total iron binding
capacity) parameters were analyzed at baseline. Women were asked to fulfill two gynecological questionnaires: a
general questionnaire, to inform about the volunteer’s general menstrual characteristics; and a MBL questionnaire, to
provide details of the duration of menstruation, number of heavy blood loss days, and number and type of pads
and/or tampons used during the heaviest bleeding day, for all consecutive menstrual periods during 16 weeks. A
MBL-score was calculated for each period and women, and its reliability determined by the Cronbach’s alpha coefficient.
Pearson’s linear correlation tests were performed between blood parameters and the MBL-score. Two clusters were
formed according the MBL-score (cluster 1: low MBL and cluster 2: high MBL).
Results: Significant higher MBL-score was observed in women who reported having a history of anemia (p = 0.015),
staining the bed at night during menstruation (p < 0.001) and suffering inter-menstrual blood loss (p = 0.044), compared
to those who did not. Women who used hormonal contraceptives presented lower MBL-scores than the others
(p = 0.004). The MBL-score was negatively associated with log-ferritin (p = 0.006) and platelet count (p = 0.011). Women
in cluster 1 presented higher ferritin (p = 0.043) than women in cluster 2.
Conclusions: We developed an easy and practical method for estimating menstrual blood loss based on a score
calculated from a questionnaire in healthy women at childbearing age. The MBL-score is highly reliable and reflects
menstrual blood loss validated by hematological and biochemical parameters.
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During a woman’s reproductive years, the time between
menarche and menopause, menstruation is a natural
and physiological monthly process. However, abnormal
bleeding intensity, menorrhagia or intracyclic bleeding,
substantially decrease women´s quality of life [1-3]. Men-
orrhagia, which is defined as an excessive uterine bleed-
ing (>80 mL of blood loss per cycle) occurring at regular
intervals, or prolonged uterine bleeding lasting more
than seven days, is a common clinical problem among
women of reproductive age and frequently results in
anemia, impairing women’s daily activities, and is often
managed by hysterectomy [4].
Iron deficiency anemia, the most common form of
anemia all over the world [5,6], has a complex etiology
and is the result of a long-term negative iron balance in
the body. A number of factors including low dietary iron
bioavailability and high iron requirement contribute to
this problem. Women at childbearing age constitute an
important risk group due to the additional iron demands
of menstruation and pregnancy [7,8].
As menstrual blood loss (MBL) has been shown to be
an important determinant in iron status, work perform-
ance and well-being [3,9], it is important to find a pre-
cise and practical method for its measurement. Several
methods for menstrual blood loss quantification have
been developed: self-estimate of menstrual loss, counting
the number of days of menstruation, counting the num-
ber of sanitary products, weighing sanitary products, full
blood count (based on hemoglobin levels), pictorial
blood loss assessment, menstrual pictogram, and chem-
ical analysis of the blood content of used sanitary prod-
ucts, also known as alkaline hematin method [2,10,11].
This method, considered the gold standard, was devel-
oped by Hallberg and Nilsson in 1964 and consists of
extracting the heme from the used tampons and pads by
sodium hydroxide and converting it to alkaline hematin,
which is later determined spectrophotometrically [12].
However, it has limited application in clinical practice as
it is expensive and requires women to collect, store and
submit all their sanitary products from one cycle/period
for analysis, which may be burdensome and even un-
acceptable for some women [10]. Moreover, it has been
suggested that up to 12% of menstrual blood could be
lost extraneously and is non-quantified [13].
Our research group has experience in studies with
iron-deficient women and has previously described that
MBL, together with diet and genetics, is an important
factor in iron deficiency etiology [14-16]. We therefore
aimed to develop an easy and practical method for esti-
mating menstrual blood loss based on a score calcu-
lated from a questionnaire and to validate it by several
hematological and biochemical parameters in women of
childbearing age.Methods
Subjects
Volunteers were recruited by different announcements
in press, university campus and web pages of Madrid.
The study was also verbally promoted at public events.
Healthy women aged 18–35 years, Caucasian, non-
smoker, non-pregnant, non-breastfeeding and non-anemic
were recruited. Exclusion criteria were as follows: amenor-
rhea (lack of menstruation in the 3 months prior to the
study), menopause, iron-metabolism-related diseases (iron
deficiency anemia, thalassemia and hemochromatosis),
chronic gastric diseases (inflammatory bowel disease,
Crohn disease, gastric ulcers, celiac disease, hemorrhagic
diseases and helicobacter pylori), renal disease or blood
donor status.
This study is part of a wider investigation comprising
health questionnaires, a genetic study and nutritional
intervention. A total of 584 women contacted the re-
search group to receive information and 289 underwent
the screening. Women who did not meet the inclusion
criteria or declined to participate were excluded and a
total of 165 women agreed to participate, completed the
study and were analyzed.
The present study was conducted according to the
guidelines laid down in the Declaration of Helsinki, and
all procedures were approved by the Clinical Research
Ethics Committees of Hospital Puerta de Hierro, Maja-
dahonda (#266, 23 May 2011) and Spanish National Re-
search Council (CSIC), Madrid, Spain. All subjects signed
informed consent.
Gynecological questionnaires
Two questionnaires were used. The first one consisted
of the volunteer´s general menstrual characteristics: age
at menarche, history of anemia, if they ever stain the bed
at night during menstruation, if they ever had inter-
menstrual blood loss and the use of any contraceptive
method (type, duration and possible change of method
in the previous 3 months and during the assay). Women
completed this questionnaire at baseline and after
16 weeks in order to track any changes.
The second questionnaire was designed to estimate
MBL and calculate a score (MBL-score); women were
asked the exact start date of menstruation, the duration
of menstruation, as well as the number of heavy blood
loss days. They were also asked the number and type of
pads and/or tampons used during the day and night
for the heaviest bleeding day (Figure 1). Women were
instructed to fill out this questionnaire for all consecu-
tive menstrual periods during 16 weeks and to do it im-
mediately after using the sanitary products, never from
memory.
To estimate the MBL of the volunteers, each kind of
pads and tampons were assigned a relative absorbance
Figure 1 Gynecological questionnaire.
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sorbency levels, and multiplied by the number of units
used reported by each subject. The absorbance numbers
were for pads: mini 1, normal, 1.5, super 2, night/
superplus 3; and for tampons: mini 0.5, regular 1, super
1.5, superplus 3.
For example: number of pads reported = 1 (night);
number of tampons reported = 4 (super). Therefore,
MBL = (1 × 3) + (4 × 1.5) = 9.
The MBL-score was calculated taking into account the
duration of menstruation, the number of heavy days and
the estimated MBL, see the ‘MBL-score formula’ subsec-
tion. This score was calculated for each women and
menstrual period.
MBL-score formula
The MBL-score was calculated as follows:
MBL‐score ¼ Number of heavy days
Number of days of menstruation
MBL
Anthropometric determinations
All participants were instructed not to deviate from their
regular habits and to maintain them during the assay. At
baseline, body weight was measured with a Seca scale
(to a precision of 100 g) and height was measured with
a stadiometer incorporated into the scale. Body mass
index (BMI) was calculated. In addition, volunteers com-
pleted a general questionnaire every month in order to
monitor possible health problems, medication use and
changes in their normal routine.Blood sampling and hematological and biochemical
determinations
All volunteers attended the laboratory facilities at base-
line. Blood samples were collected by venipuncture after
a 12-h fasting period. Serum was obtained after centrifu-
gation at 1000 g for 15 minutes. Hematocrit, hemoglobin,
and erythrocyte, leucocyte and platelet counts were deter-
mined using the Symex NE 9100 automated hematology
analyzer (Symex, Kobe, Japan). Serum iron, serum ferritin
and serum transferrin were determined by the Modular
Analytics Serum Work Area analyzer (Roche, Basel,
Switzerland). Total iron binding capacity (TIBC) and
transferrin saturation were calculated as follows: TIBC
(μmol/L) = 25.1 × transferrin (g/L); transferrin saturation =
serum iron (μmol/L)/TIBC × 100.
All determinations were subjected to the ISO-9001-
2000 requirements.
Statistical analysis
Data are presented as means with their standard devia-
tions. A normal distribution of variables was determined
by the Kolmogorov-Smirnov test and serum ferritin
values were log transformed for statistical testing. Reli-
ability of the MBL score was analyzed by the Cronbach’s
alpha coefficient. A value >0.70 is usually regarded as
satisfactory and the nearer this coefficient is to 1 the
more reliable it is [17]. ANOVA was applied to the mean
MBL-score, in order to compare women who reported a
history of anemia, staining the bed at night during men-
struation, inter-menstrual blood loss and the use of a
hormonal contraceptive method, with those women who
did not. Pearson’s linear correlation tests between MBL-
score and hematological and biochemical parameters were




Yes (34%, n = 56) 4.0 ± 2.0 0.015
No 3.2 ± 1.9
Stain the bed at night during menstruation
Yes (29%, n = 48) 4.6 ± 1.9 <0.001
No 3.0 ± 1.8
Inter-menstrual blood loss
Yes (8.5%, n = 14) 4.5 ± 1.9 0.044
No 3.3 ± 1.9
Hormonal contraceptive use
Yes (30.5%, n = 50) 2.8 ± 1.7 0.004
No 3.7 ± 2.0
MBL, menstrual blood loss.
Percentage of women and n are indicated in parenthesis.
Values are expressed as mean ± SD. Significant differences between groups
by ANOVA.
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MBL-score by means of k-means cluster analysis. Two
clusters were formed and differences between clusters were
analyzed by ANOVA. Hormonal contraceptive use was an-
alyzed as a random effect factor. A p value of <0.05 was
considered significant. The IBM SPSS statistical package
for Windows (version 20.0) was used to analyze the data.
Results
Baseline characteristics of the participating women are
shown in Table 1. The Cronbach’s alpha coefficient for
the calculated MBL-score was 0.83.
A significantly higher MBL-score was observed in women
who reported having a history of anemia (p = 0.015), stain-
ing the bed at night during menstruation (p < 0.001) and
having inter-menstrual blood loss (p = 0.044), compared to
those who did not (Table 2).
None of the volunteers used intrauterine device as a
contraceptive method and 30.5% were using hormonal
contraceptives (24.4% contraceptive pills and 6.1% vagi-
nal ring) during the study. It was observed that women
who used hormonal contraceptive methods presented
lower MBL-score than those who did not (p = 0.004)
(Table 2).Table 1 Baseline characteristics of the women
Mean ± SD
Age (years) 25.3 ± 4.3
Body Mass Index (kg/m2) 21.6 ± 3.0
Age at menarche (years) 12.7 ± 1.5
Cycle length (days) 30.2 ± 5.0
Length of period (days) 5.0 ± 1.2
Number of heavy days 1.9 ± 0.8
Menstrual blood loss (units) 8.6 ± 3.5
Total erythrocytes (×10−12/L) 4.4 ± 0.3
Hematocrit (%) 39.3 ± 2.6
Mean corpuscular volume (fL) 90.4 ± 4.3
Red blood cell distribution width (%) 13.8 ± 0.9
Hemoglobin (g/dL) 13.3 ± 0.8
MCH (pg) 30.5 ± 1.7
Serum iron (μg/dL) 90.0 ± 41.3
Serum ferritin (ng/mL) 35.2 ± 27.0
Serum transferrin (mg/dL) 291.1 ± 57.0
Transferrin saturation (%) 23.1 ± 12.1
TIBC (μmol/L) 73.1 ± 14.3
Platelets (×109/L) 221.0 ± 44.2
Mean platelet volume (fL) 8.8 ± 1.0
Platelet distribution width (%) 16.2 ± 0.5
Leucocytes (×109/L) 6.6 ± 1.5
MCH, mean corpuscular hemoglobin; TIBC, total iron binding capacity.The MBL-score was negatively associated with log-
ferritin (p = 0.006) and platelet count (p = 0.011). The
correlations with the other hematological and biochem-
ical parameters were not significant.
Cluster analysis of the MBL-score formed two differ-
ent groups (Table 3): cluster 1 (women with low MBL)
and cluster 2 (women with high MBL). Serum ferritin
and platelet count were significantly lower (p = 0.002
and p = 0.022, respectively) and mean platelet volume
significantly higher (p = 0.006) in cluster 2 respect to
cluster 1. However, when hormonal contraceptive use
was included in the model, differences between clusters
in serum ferritin remained significant (p = 0.043) but
those in platelet count and platelet volume resulted not
significant. The other blood parameters were not signifi-
cantly different between clusters.
Discussion
This study presents an easy and feasible method for esti-
mating menstrual blood losses, based on a score calcu-
lated from a questionnaire which is clearly related to
history of anemia, several gynecological parameters, hor-
monal contraceptive use, serum ferritin and platelets, in
healthy young women.
The MBL-score is based on three items of the
woman's menstrual period that are obtained from a
questionnaire that is filled out during menstruation and
not from memory. Moreover, the questionnaire was sim-
ple and women declared it was easy to complete.
Methods based on questionnaires for assessing MBL are
reported to be in agreement with the gold standard alka-
line hematin method [11,18]. Reliability of the MBL-
Table 3 Iron biomarkers according to cluster score
Cluster score
Low blood loss (n = 117) High blood loss (n = 48) p
MBL-score 2.4 ± 0.9 (0.5 - 4.2) 6.0 ± 1.4 (4.3 - 10.6) -
Total erythrocytes (×10−12/L) 4,4 ± 0,3 4,3 ± 0,3 NS
Hematocrit (%) 39,4 ± 2,6 39,0 ± 2,4 NS
Mean corpuscular volume (fL) 90,6 ± 4,2 90,0 ± 4,6 NS
Red blood cell distribution width (%) 13,8 ± 1,0 14,0 ± 0,8 NS
Hemoglobin (g/dL) 13,3 ± 0,9 13,1 ± 0,8 NS
MCH (pg) 30,6 ± 1,6 30,3 ± 1,7 NS
Serum iron (μg/dL) 91,6 ± 39,9 86,1 ± 44,9 NS
Serum ferritin (ng/mL) 38,8 ± 27,5 26,2 ± 23,4 0.002*
Serum transferrin (mg/dL) 291,6 ± 57,9 289,8 ± 55,1 NS
Transferrin saturation (%) 23,6 ± 12,2 21,7 ± 11,9 NS
TIBC (μmol/L) 73,2 ± 14,5 72,8 ± 13,9 NS
Platelets (×109/L) 226.0 ± 44,8 208,5 ± 40,6 0.022¶
Mean platelet volume (fL) 8.7 ± 0.1 9.2 ± 0.9 0.006¶
Platelet distribution width (%) 16.2 ± .4935 16.3 ± .5118 NS
Leucocytes (×109/L) 6.7 ± 1.6 6.3 ± 1.4 NS
Values are expressed as mean ± SD (range). MCH, mean corpuscular hemoglobin; TIBC, total iron binding capacity. Significant differences by ANOVA; *p = 0.043
and ¶ NS with hormonal contraceptive use as a random factor.
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alpha coefficients provided by George and Mallery [19]: >
0.9, excellent; > 0.8, good; > 0.7, acceptable, > 0.6, ques-
tionable; > 0.5, poor; and < 0.5, unacceptable.
Women, who reported having a history of anemia,
staining the bed at night during menstruation or having
inter-menstrual blood loss, presented higher scores com-
pared to women who did not report such problems. On
the contrary, women who used hormonal contraceptives
presented lower MBL-score than those who did not use
them. These results support the reasonable accuracy of
our score and are in agreement with the literature
[20-22]. In addition, the higher the MBL-score the lower
the serum ferritin levels which confirms that menstrual
bleeding is an important determinant of iron status in
women at childbearing age [9]. In this regard, identifying
women with high menstrual blood loss could be a key
strategy to prevent iron deficiency anemia [7] and to
avoid further unnecessary exams.
The fact that women with lower MBL presented higher
platelet count, although is in agreement with few case
reports in iron deficiency anemic women with menor-
rhagia [23,24], contrasts with the usual diagnosis of
thrombocytosis in iron deficiency anemia [25]. In the
present study volunteers were healthy, non-anemic and
all their hematological and biochemical values includ-
ing platelets were within normal ranges and it was
observed that hormonal contraceptive use had a confound-
ing influence. In this regard, it is known that hormonalcontraceptives increase platelets and the risk of thrombo-
embolism [26].
Therefore, we suggest that the MBL-scores of the
present study should be considered as reference values
of healthy young menstruating women. The range was
between 0.5 and 10.6 and mean values were 2.4 and 6.0,
for women with low and high MBL respectively, thus
these results could be a starting point in the application
of a MBL-score as a risk marker for anemia or other re-
lated gynecological disorders associated with menses.
According to Munro [27], our group of women could
be classified at normal limits of regularity, duration and
frequency of menstrual periods when the 5th to 95th cen-
tiles are utilized. Menorrhagia was only observed in 6
women who reported a length of period >7 days. Be-
cause the classic definition of menorrhagia (>80 mL of
blood loss per cycle) is rarely used clinically due to the
difficult to measure menstrual blood loss [4], it could be
of interest to apply our questionnaire in women with
menorrhagia or other health problems that could affect
menstruation, such as malnutrition, anorexia or exces-
sive exercise.
Conclusions
We have developed an easy and practical method for
estimating menstrual blood loss based on a score calcu-
lated from a questionnaire in healthy women of child-
bearing age. It is highly reliable and reflects menstrual
blood loss validated by biochemical parameters.
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